Doctors theorized that the anti- inflammatory nutrient, resveratrol, might slow the progression of Alzheimer’s disease (AD). In the first study of its kind, doctors were able to show that resveratrol appeared to penetrate the blood/brain barrier, with measurable levels detected in cerebrospinal fluid.